Epidemiological, social, diagnostic and economic evaluation of population screening for genital chlamydial infection
Open accessThe DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Abstract
OBJECTIVES: To investigate epidemiological, social, diagnostic and economic aspects of chlamydia screening in non-genitourinary medicine settings. METHODS: Linked studies around a cross-sectional population-based survey of adult men and women invited to collect urine and (for women) vulvovaginal swab specimens at home and mail these to a laboratory for testing for Chlamydia trachomatis. Specimens were used in laboratory evaluations of an amplified enzyme immunoassay (PCE EIA) and two nucleic acid amplification tests [Cobas polymerase chain reaction (PCR), Becton Dickinson strand displacement amplification (SDA)]. Chlamydia-positive cases and two negative controls completed a risk factor questionnaire. Chlamydia-positive cases were invited into a randomised controlled trial of partner notification strategies. Samples of individuals testing negative completed psychological questionnaires before and after screening. In-depth interviews were conducted at all stages of screening. Chlamydia transmission and cost-effectiveness of screening were investigated in a transmission dynamic model. SETTING AND PARTICIPANTS: General population in the Bristol and Birmingham areas of England. In total, 19,773 women and men aged 16-39 years were randomly selected from 27 general practice lists. RESULTS: Screening invitations reached 73% (14,382/19,773). Uptake (4731 participants), weighted for sampling, was 39.5% (95% CI 37.7, 40.8%) in women and 29.5% (95% CI 28.0, 31.0%) in men aged 16-39 years. Chlamydia prevalence (219 positive results) in 16-24 year olds was 6.2% (95% CI 4.9, 7.8%) in women and 5.3% (95% CI 4.4, 6.3%) in men. The case-control study did not identify any additional factors that would help target screening. Screening did not adversely affect anxiety, depression or self-esteem. Participants welcomed the convenience and privacy of home-sampling. The relative sensitivity of PCR on male urine specimens was 100% (95% CI 89.1, 100%). The combined relative sensitivities of PCR and SDA using female urine and vulvovaginal swabs were 91.8% (86.1, 95.7, 134/146) and 97.3% (93.1, 99.2%, 142/146). A total of 140 people (74% of eligible) participated in the randomised trial. Compared with referral to a genitourinary medicine clinic, partner notification by practice nurses resulted in 12.4% (95% CI -3.7, 28.6%) more patients with at least one partner treated and 22.0% (95% CI 6.1, 37.8%) more patients with all partners treated. The health service and patients costs (2005 prices) of home-based postal chlamydia screening were 21.47 pounds (95% CI 19.91 pounds, 25.99) per screening invitation and 28.56 pounds (95% CI 22.10 pounds, 30.43) per accepted offer. Preliminary modelling found an incremental cost-effectiveness ratio (2003 prices) comparing screening men and women annually to no screening in the base case of 27,000 pounds/major outcome averted at 8 years. If estimated screening uptake and pelvic inflammatory disease incidence were increased, the cost-effectiveness ratio fell to 3700 pounds/major outcome averted. CONCLUSIONS: Proactive screening for chlamydia in women and men using home-collected specimens was feasible and acceptable. Chlamydia prevalence rates in men and women in the general population are similar. Nucleic acid amplification tests can be used on first-catch urine specimens and vulvovaginal swabs. The administrative costs of proactive screening were similar to those for opportunistic screening. Using empirical estimates of screening uptake and incidence of complications, screening was not cost-effective.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Discovery of Grounded Theory: Strategies for Qualitative Research
Glaser, B. G., & Strauss, A. L. (2017) · Aldine (Routledge reprint) · doi:10.4324/9780203793206 · Cited by 25,789
Methods for the Economic Evaluation of Health Care Programmes
Drummond, M. E., Sculpher, M. J., Torrance, G. W., O’Brien, B. J., & Stoddart, G. L. (2005) · doi:10.1093/oso/9780198529446.001.0001 · Cited by 13,648
Hospital Anxiety and Depression Scale
Zigmond, A. S., & Snaith, R. P. (2013) · PsycTESTS Dataset · doi:10.1037/t03589-000 · Cited by 946
Sexual behaviour in Britain: Partnerships, practices, and HIV risk behaviours.
Johnson, A. M., Mercer, C. H., Erens, B., Copas, A. J., McManus, S., Wellings, K., Fenton, K. A., Korovessis, C., Macdowall, W., Nanchahal, K., et al. (2001) · The Lancet · doi:10.1016/s0140-6736(01)06883-0 · Cited by 815
Golden, M. R., Whittington, W. L. H., Handsfield, H. H., Hughes, J. P., Stamm, W. E., Hogben, M., Clark, A., Malinski, C., Helmers, J. R. L., Thomas, K. K., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa041681 · Cited by 470
Cited by
Price, M. J., Ades, A., Soldan, K., Welton, N. J., Macleod, J., Simms, I., DeAngelis, D., Turner, K. M., & Horner, P. J. (2016) · Health Technology Assessment · doi:10.3310/hta20220 · Cited by 494
“A slightly different calculation based on similar assumptions was proposed by Low et al.(15) But in both cases the EP rate was assumed to be independent of the PID rate, which runs counter to what is known about their relationship.”
BackgroundMethodSelf-citationMeads, C., Cnossen, J., Meher, S., Juarez-Garcia, A., ter Riet, G., Duley, L., Roberts, T., Mol, B., van der Post, J., Leeflang, M., et al. (2008) · Health Technology Assessment · doi:10.3310/hta12060 · Cited by 323
Self-citationGlobal control of sexually transmitted infections
Low, N., Broutet, N., Adu-Sarkodie, Y., Barton, P., Hossain, M., & Hawkes, S. (2006) · The Lancet · doi:10.1016/s0140-6736(06)69482-8 · Cited by 279
Self-citationAlthaus, C. L., Turner, K. M., Mercer, C. H., Auguste, P., Roberts, T. E., Bell, G., Herzog, S. A., Cassell, J. A., Edmunds, W. J., White, P. J., et al. (2014) · Health Technology Assessment · doi:10.3310/hta18020 · Cited by 101
“(a) Natsal-2;(8) (b) Kretzschmar model;(38) (c) Turner model;(40) and (d) ClaSS model.(39) The width of each bar represents the proportion of people who have had a given number of sexual partners within the last year (the legend shows the distribution of sexual partner numbers).”
BackgroundSelf-citationZiebe, S., Devroey, P., & on behalf of the State of the ART 2007 Workshop Group (2008) · Human Reproduction Update · doi:10.1093/humupd/dmn038 · Cited by 77
Metadata
- Authors
- Low, N., McCarthy, A., Macleod, J., Salisbury, C., Campbell, R., Roberts, T., Horner, P., Skidmore, S., Sterne, J., Sanford, E., Ibrahim, F., Holloway, A., Patel, R., Barton, P., Robinson, S., Mills, N., Graham, A., Herring, A., Caul, E., Davey Smith, G., Hobbs, F., Ross, J., & Egger, M.
- Venue
- Health Technology Assessment
- Published
- 2007-03
- Volume
- 11
- Issue
- 8
- Pages
- iii-iv, ix
- ISSN
- 1366-5278 (ISSN-L)
- 2046-4924
- OpenAlex
- W2020997773
- Cited by
- 164
- References
- 5
- FWCI
- 12.12
- Type
- journal article
- Language
- en
- Open access
- diamond
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.